Institutional Manager · CIK 0001388325
NOVO HOLDINGS A/S
HELLERUP, G7 · File #028-16231
Latest AUM
$1.29B
Positions
24
Top-10 Concentration
71.3%
Filings
10
Portfolio Value Over Time
2024-03
2024-06
2024-09
2024-12
2025-03
2025-06
2025-09
2025-12
Biggest QoQ Changes
Ranked by conviction flow (share change × current price) so mark-to-market moves don't dominate. Price effect column shows how much of the $ change was just the stock moving.
| Action | Issuer | Ticker / CUSIP | Δ Shares | Flow ($) | Price Effect |
|---|---|---|---|---|---|
| EXITED | VANGUARD INDEX FDS | 922908769 | -1,038,550 | -$340.8M | $0 |
| EXITED | MERUS N V | N5749R100 | -750,000 | -$70.6M | $0 |
| NEW | MAPLIGHT THERAPEUTICS INC | MPLT | +3,686,622 | +$64.8M | $0 |
| ADD | BROOKFIELD CORP | 11271J107 | +1,165,415 | +$53.5M | -$52.9M |
| EXITED | RECURSION PHARMACEUTICALS IN | 75629V104 | -7,929,835 | -$38.7M | $0 |
| REDUCE | ASML HOLDING N V | ASMLF | -31,890 | -$34.1M | +$14.8M |
| REDUCE | ZENAS BIOPHARMA INC | ZBIO | -550,000 | -$20.0M | +$28.2M |
| ADD | 4D MOLECULAR THERAPEUTICS IN | FDMT | +1,650,737 | +$12.4M | -$2.4M |
| ADD | APOGEE THERAPEUTICS INC | APGE | +70,000 | +$5.3M | +$17.9M |
| ADD | ENLIVEN THERAPEUTICS INC | ELVN | +53,740 | +$827,596 | -$7.2M |
Sector Allocation
Filing History
- 13F HOLDINGS REPORTQ/E Dec 202524 pos · $1.29B
- 13F HOLDINGS REPORTQ/E Sep 202527 pos · $1.55B
- 13F HOLDINGS REPORTQ/E Jun 202529 pos · $1.42B
- 13F HOLDINGS REPORTQ/E Mar 202531 pos · $1.31B
- 13F HOLDINGS REPORTQ/E Dec 202434 pos · $1.65B
- 13F HOLDINGS REPORTQ/E Sep 202437 pos · $2.01B
- 13F HOLDINGS REPORT (Amended)Q/E Jun 202438 pos · $1.85B
- 13F HOLDINGS REPORTQ/E Jun 202439 pos · $1.72B
- 13F HOLDINGS REPORTQ/E Mar 202435 pos · $1.45B
- 13F HOLDINGS REPORTQ/E Dec 202340 pos · $1.35B
Top 20 Holdings — Dec 2025
| # | Issuer | Ticker | Shares | Value | % of Portfolio |
|---|---|---|---|---|---|
| 1 | BROOKFIELD CORP | 11271J107 | 3,496,245 | $160.4M | 12.46% |
| 2 | EDGEWISE THERAPEUTICS INC | EWTX | 5,350,000 | $132.8M | 10.31% |
| 3 | ASML HOLDING N V | ASMLF | 113,946 | $121.9M | 9.47% |
| 4 | MIRUM PHARMACEUTICALS INC | MIRM | 1,264,028 | $99.8M | 7.75% |
| 5 | SALESFORCE INC | CRM | 330,187 | $87.5M | 6.79% |
| 6 | CRINETICS PHARMACEUTICALS IN | CRNX | 1,625,000 | $75.6M | 5.87% |
| 7 | VIRIDIAN THERAPEUTICS INC | VRDN | 2,380,000 | $74.1M | 5.75% |
| 8 | MAPLIGHT THERAPEUTICS INC | MPLT | 3,686,622 | $64.8M | 5.03% |
| 9 | ZENAS BIOPHARMA INC | ZBIO | 1,450,000 | $52.6M | 4.09% |
| 10 | PHARVARIS N V | PHVS | 1,750,000 | $48.6M | 3.77% |
| 11 | APOGEE THERAPEUTICS INC | APGE | 570,000 | $43.0M | 3.34% |
| 12 | VAXCYTE INC | PCVX | 916,160 | $42.3M | 3.28% |
| 13 | BIOMARIN PHARMACEUTICAL INC | BMRN | 660,000 | $39.2M | 3.05% |
| 14 | ARRIVENT BIOPHARMA INC | AVBP | 1,942,142 | $39.1M | 3.03% |
| 15 | ALIBABA GROUP HLDG LTD | BBAAY | 257,327 | $37.7M | 2.93% |
| 16 | INSMED INC | INSM | 200,000 | $34.8M | 2.70% |
| 17 | CELLDEX THERAPEUTICS INC NEW | CLDX | 1,200,000 | $32.6M | 2.53% |
| 18 | 4D MOLECULAR THERAPEUTICS IN | FDMT | 3,650,737 | $27.4M | 2.13% |
| 19 | BRIDGEBIO ONCOLOGY THERAPEUT | BBOT | 1,961,317 | $24.6M | 1.91% |
| 20 | ENLIVEN THERAPEUTICS INC | ELVN | 1,480,000 | $22.8M | 1.77% |